Watch Pfizer’s $14 Billion Medivation Deal Boosts Cancer Drug Roster Business News Video

28 sec read

“Pfizer Inc (PFE.N), beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc (MDVN.O) for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company’s growing oncology roster.

“Medivation shares jumped nearly 20 percent to close at $80.42, just shy of the offer price of $81.50 per share. Shares of Pfizer, the largest U.S. drugmaker, were down 0.4 percent at $34.84.

“The offer is a 55-percent premium to Sanofi SA’s (SASY.PA) initial bid to buy Medivation for $52.50 per share in April, which pushed the San Francisco-based company to put itself up for sale.

“It represents a 118-percent increase since Reuters reported on March 30 that Medivation had hired JP Morgan to handle interest from companies in a potential acquisition.”

Read more at Reuters

Watch Professional Gamer Ninja Reveals He Has Skin Cancer…

“American gamer and Twitch superstar Tyler “Ninja” Blevins revealed he was diagnosed with melanoma, a form of skin cancer. “The 32-year-old, who boasts 19...
JM
14 sec read

Watch Brittany Snow Details Divorce Drama With Ex Tyler…

“Two years after her dramatic split from Selling the OC star Tyler Stanaland, Brittany Snow is opening up about her ex-husband’s seemingly unfaithful behavior...
JM
16 sec read

Watch Dollar Tree to Raise Prices Again in 2024…

“Shoppers at Dollar Tree could soon end up with sticker shock. “In an earnings call held this month, Dollar Tree, Inc. announced it’ll be...
JM
25 sec read